An interaction among factors in which the combined effect on an outcome is less than the effect expected from their individual effects according to a prespecified comparison rule; antagonism implies inhibition, competition, or attenuation among factors but is scale‑ and context‑dependent.

Principle

Antagonism is identified relative to a chosen null expectation (additive, multiplicative, etc.); detection requires defining that expectation and excluding alternative explanations such as saturation, ceiling effects or competing risks.

Demonstration

Illustrative scenario — Situation: Two drugs are given together. Recognition: Each drug alone reduces symptom score by 20%; the expected additive effect is 40%. Action: Combined therapy produces only a 15% reduction. Consequence: The observed sub‑additive outcome meets the prespecified criterion for antagonism, prompting review of drug interactions and a change in therapeutic strategy.

Misapplication

Interpreting any subadditive statistical result as biological antagonism without considering measurement ceilings, pharmacokinetic interactions, dose differences or inappropriate null model selection.

Consequence

Recognizing antagonism can prevent ineffective or harmful combinations and guide selection of alternative treatments; misidentifying antagonism may unnecessarily withhold beneficial combined strategies.

Reversal

Apparent antagonism can convert to synergy at different doses, timings, or in different populations; mechanism‑specific interactions (e.g., competitive receptor binding) may produce context‑limited antagonism.

Boundary

Clearly within: combined effect materially below the prespecified expected effect after accounting for artifacts. Boundary case: combined effect equals expectation (no interaction). Clearly outside: independent or additive effects matching the null.

Semantic Tension

Avoiding harm (exclude antagonistic combinations) versus achieving maximal efficacy (combine agents for synergy); decisions depend on clinical or regulatory priorities and acceptable trade‑offs.

Synthesis

Antagonism denotes a reproducible attenuation relative to a declared expectation; its identification depends on scale, mechanism, dose and timing and must be distinguished from measurement or model artifacts.